GlassScriptPhysician profile
Michael T Nolen
NPI 1164515318
$14,589.78
in general payments reported to CMS, 2019-2025
27 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,809 · 2020: $1,336 · 2021: $1,374 · 2022: $2,117 · 2023: $1,269 · 2024: $4,075 · 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,392 · Travel and Lodging: $1,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,392.30 |
| Travel and Lodging | $1,561.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,497.29 | 2019-2025 | Epic, Sjm Regent, Navitor |
| Abiomed | $3,285.55 | 2019-2025 | Impella |
| Atricure, INC. | $2,154.04 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,387.25 | 2021-2025 | Corevalve Evolut R, Penditure, Penditure |
| Edwards Lifesciences Corporation | $798.73 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Endologix LLC | $413.83 | 2020 | |
| Zimmer Biomet Holdings, INC. | $375.94 | 2019-2025 | Sternalock Blu System |
| Stryker Corporation | $351.31 | 2022-2024 | Na |
| Elutia, INC. | $281.66 | 2021-2023 | |
| Lemaitre Vascular, INC. | $273.83 | 2022-2025 | Restoreflow, Pruitt F3 Carotid Shunt |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $203.64 | 2024 | |
| Shockwave Medical, INC | $188.12 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $178.44 | 2020 | |
| Ethicon US, LLC | $151.02 | 2020-2025 | Vistaseal, Prolene, Ethicon |
| Bolton Medical INC | $146.82 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $146.34 | 2022-2025 | Teg6s Hemostasis System |
| Livanova USA, INC. | $145.55 | 2021 | |
| Silk Road Medical, INC. | $137.54 | 2022 | |
| Boston Scientific Corporation | $118.61 | 2020-2025 | General - Therapies |
| Kls-Martin L.P. | $108.68 | 2022-2025 | |
| Z-Medica, LLC | $104.72 | 2020 | |
| Smith+Nephew, INC. | $36.87 | 2021-2022 | |
| Midsouth Orthopedics INC. | $31.05 | 2023 | |
| Teleflex LLC | $22.86 | 2024 | Quikclot |
| Chiesi USA, INC. | $19.40 | 2019 | |
| Medtronic Vascular, INC. | $16.45 | 2019 | |
| Kci USA, INC. | $14.24 | 2023 | Bair Paws, Bair Hugger |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nolen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.